{"id":1063217,"date":"2010-06-18T08:17:58","date_gmt":"2010-06-18T08:17:58","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/patent-application-levels-of-oct1-as-a-method-of-identifying-cscs\/"},"modified":"2024-08-17T20:27:55","modified_gmt":"2024-08-18T00:27:55","slug":"patent-application-levels-of-oct1-as-a-method-of-identifying-cscs","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/patent-application-levels-of-oct1-as-a-method-of-identifying-cscs.php","title":{"rendered":"Patent application: Levels of Oct1 as a method of identifying CSCs"},"content":{"rendered":"<p><a title=\"(WO2010065400) Cancer Biomarker and Methods of Using Thereof\" href=\"http:\/\/www.wipo.int\/patentscope\/search\/en\/detail.jsf?docId=WO2010065400&amp;recNum=1&amp;docAn=US2009065742&amp;maxRec=&amp;office=&amp;prevFilter=&amp;sortOption=Relevance&amp;queryString=&amp;tab=PCTClaims\" target=\"_blank\" rel=\"noopener\">(WO2010065400) Cancer Biomarker and Methods of Using Thereof<\/a>.<\/p><p>Excerpt from <a title=\"PCT Biblio. Data\" href=\"http:\/\/www.wipo.int\/patentscope\/search\/en\/detail.jsf?docId=WO2010065400&amp;recNum=1&amp;docAn=US2009065742&amp;maxRec=&amp;office=&amp;prevFilter=&amp;sortOption=Relevance&amp;queryString=&amp;tab=PCT+Biblio.+Data\" target=\"_blank\" rel=\"noopener\">PCT Biblio. Data<\/a>: <\/p><blockquote><p><em>International Application No.<\/em>: PCT\/US2009\/065742<br><em>Publication Date<\/em>: 10.06.2010<\/p><\/blockquote><p>Excerpt from <a href=\"http:\/\/www.wipo.int\/patentscope\/search\/en\/detail.jsf?docId=WO2010065400&amp;recNum=1&amp;docAn=US2009065742&amp;maxRec=&amp;office=&amp;prevFilter=&amp;sortOption=Relevance&amp;queryString=&amp;tab=PCTDescription\" target=\"_blank\" rel=\"noopener\">Description<\/a>: <\/p><blockquote><p>Described herein are biomarkers which can be used for identifying a subject at risk for or evaluating the progression of cancer. In certain aspects, these biomarkers can be used to identify cancer stem cells. These biomarkers can include Octl or molecular variants thereof and downstream targets of Octl. In addition, described herein are methods for reducing the expression of these biomarkers associated with cancer.<\/p><\/blockquote><div><img loading=\"lazy\" decoding=\"async\" width=\"1\" height=\"1\" src=\"http:\/\/www.longevitymedicine.tv\/wp-content\/plugins\/wp-o-matic\/cache\/ff256_35997458635844014-5053138809736255895?l=cancerstemcellnews.blogspot.com\" alt=\"\" style=\"padding-left:10px; padding-right: 10px;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>(WO2010065400) Cancer Biomarker and Methods of Using Thereof.Excerpt from PCT Biblio. Data: International Application No.: PCT\/US2009\/065742Publication Date: 10.06.2010Excerpt from Description: Described herein are biomarkers which can be used for identifying a subject at risk for or evaluating the progression of &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/patent-application-levels-of-oct1-as-a-method-of-identifying-cscs.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25,1246878],"tags":[],"class_list":["post-1063217","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy","category-stem-cells"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063217"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1063217"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1063217\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1063217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1063217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1063217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}